| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/18/1993 | DE4130933A1 Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln New (beta) -carbolinderivate whose production and use in medicinal products |
| 03/18/1993 | CA2117196A1 Process for the preparation of the dextrogyral isomer of an isoindolinone derivative |
| 03/18/1993 | CA2115844A1 Antidepressant polycyclic imides |
| 03/18/1993 | CA2115161A1 New compounds |
| 03/18/1993 | CA2095847A1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 03/18/1993 | CA2093009A1 Use of antagonists or partial agonists on the 5-ht 1a receptor for the treatment and prevention of cognitive disorders |
| 03/17/1993 | EP0532456A1 1-Acylpiperidine derivatives and their use as substance P antagonists |
| 03/17/1993 | EP0532410A1 N-substituted heterocyclic derivatives as angiotensin II inhibitors |
| 03/17/1993 | EP0532398A1 N-(4,7-dimethoxyindan-2-yle)-1-(phenylcarbonyl)-N-propyle-piperidine-4-methane amines, their preparation and their therapeutical application |
| 03/17/1993 | EP0532348A2 A tramadol N-oxide material, enantiomers and compositions thereof, and their use |
| 03/17/1993 | EP0532178A1 Methanoanthracenes as dopamine antagonists |
| 03/17/1993 | EP0532177A1 Methanoanthracenes as dopamine antagonists |
| 03/17/1993 | EP0532054A1 Process for preparing alpha,alpha-disubstituted aromatics and heteroaromatics as cognition enhancers |
| 03/17/1993 | EP0532027A1 Cyclic nitrones, their preparation and pharmaceutical compositions containing them |
| 03/17/1993 | EP0531461A1 Biologically active peptides containing d-2-alkyltryptophan. |
| 03/17/1993 | EP0435913B1 Effervescent tablet |
| 03/17/1993 | CN1069973A Corbostyril derivatives and pharmaceutical compostions contaiming same |
| 03/17/1993 | CN1069969A Synthetic aryl polyamines as exicitatory/amino acid neurotransmitter antagonists |
| 03/17/1993 | CN1020103C 2,3,4,5,6,7-hexahydro-2,7-methylene-1,5-benzoxazonin and 1,4-benzoxazonin |
| 03/17/1993 | CN1020102C Preparation for bicyclic carboxylic ether and bicyclic carboxylic amide |
| 03/17/1993 | CN1020101C Process for preparation of tricycle kentones |
| 03/17/1993 | CN1020095C Process for dichloroaniline derivatives |
| 03/17/1993 | CN1020093C 1-phenyl -3-naphthalenyloxypropanamines |
| 03/16/1993 | US5194614 Antiischemic agents, analgesics, immunology, sedatives or hypoglycemic agents |
| 03/16/1993 | US5194448 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders |
| 03/16/1993 | US5194440 Treatment for migraine; selective agonist |
| 03/16/1993 | US5194437 Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders |
| 03/16/1993 | US5194430 Heterocyclic-nmda antagonists |
| 03/16/1993 | CA1314485C Pharmaceutical composition for piperidinoalkanol-decongestant combination |
| 03/14/1993 | WO1993006100A1 NEW β-CARBOLIN DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS |
| 03/14/1993 | CA2096138A1 .beta.-carboline derivatives their production and use in pharmaceutical agents |
| 03/12/1993 | WO1993004684A1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 03/12/1993 | CA2095826A1 4-arylpiperazines and 4-arylpiperidines |
| 03/11/1993 | CA2077967A1 N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 03/10/1993 | EP0531219A1 Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs |
| 03/10/1993 | EP0531155A1 Cerebral-Activating Compositions |
| 03/10/1993 | EP0530446A2 Use of sulfur containing carboxylic acids for combatting pathophysiologic excitatory disorders and related diseases as well as allergic diseases and their preparation as medicament |
| 03/10/1993 | EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof |
| 03/10/1993 | EP0439570B1 A novel use of beta-receptor blocking agents for treatment of menieres' disease |
| 03/10/1993 | CN1069733A 6-Oxo-azepinoindole and process for producing same and intermediate and application as pharmaceutical |
| 03/10/1993 | CN1069726A Medicaments |
| 03/09/1993 | US5192805 Use of acetyl l-carnitine in the therapeutic treatment of coma |
| 03/09/1993 | US5192797 Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application |
| 03/09/1993 | US5192795 Cognition activators |
| 03/09/1993 | US5192775 New aminomethylpiperidine compounds |
| 03/09/1993 | US5192773 Immunosuppressive compounds |
| 03/09/1993 | US5192770 Serotonergic alpha-oxoacetamides |
| 03/09/1993 | US5192765 Smooth muscle, bowel, bladder and airway diseases |
| 03/09/1993 | US5192763 Antiischemic agents, anticonvulsants |
| 03/09/1993 | US5192759 Derivatives of 1,2,3,4-tetrahydronaphtylamine endowed with nootropic activity and pharmaceutical compositions containing same |
| 03/09/1993 | US5192754 Treatment with steroids |
| 03/09/1993 | US5192753 Anti-rheumatoid arthritic drugs in the treatment of dementia |
| 03/09/1993 | US5192751 Administering a decahydroisoquinoline derivative |
| 03/09/1993 | US5192527 Method of reversing local anesthesia and reagent system therefor |
| 03/09/1993 | CA1314290C Hydroxamic acids of 7-oxabicycloheptane substituted ethers |
| 03/09/1993 | CA1314287C Nitrogen-containing cycloalphatic compounds having an amino acid radical and a pyridine radical |
| 03/09/1993 | CA1314226C Anti-dementia agent |
| 03/09/1993 | CA1314218C Remote administration of hyaluronic acid to mammals |
| 03/07/1993 | CA2077589A1 Cerebral-activating extract |
| 03/04/1993 | WO1993004068A1 Cns active tetrahydrobenzothienopyridines |
| 03/04/1993 | WO1993004041A1 Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists |
| 03/04/1993 | WO1993004040A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 03/04/1993 | WO1993004036A1 Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists |
| 03/04/1993 | WO1993003746A1 Preparation of medicaments containing the peptidoglycan monomer or its derivatives |
| 03/04/1993 | WO1993003732A1 Gaba receptor modulators |
| 03/04/1993 | WO1993003726A1 Muscarinic agonists |
| 03/04/1993 | WO1993003725A1 5-ht4 receptor antagonists |
| 03/04/1993 | WO1993000330A3 Azanorbornane derivatives |
| 03/04/1993 | WO1993000313A3 Sigma receptor ligands and the use thereof |
| 03/04/1993 | WO1993000094A3 Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine |
| 03/04/1993 | DE4135551A1 Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen Antagonists or partial agonists use of the 5-HT1A receptor for the treatment and prevention of cognitive impairment |
| 03/04/1993 | CA2116024A1 5-ht4 receptor antagonists |
| 03/04/1993 | CA2115270A1 The use of the peptidoglycan monomer (pgm), its n-acyl derivatives, and its metal complexes in the preparation of medicaments for the correction of the immunosuppressive and hepatosuppressive states of the organism |
| 03/04/1993 | CA2114935A1 Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists |
| 03/04/1993 | CA2114798A1 Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists |
| 03/04/1993 | CA2112397A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 03/03/1993 | EP0530166A2 3-Hydroxy anthranilic acid derivatives for inhibiting 3-hydroxy anthranilate oxygenase |
| 03/03/1993 | EP0530087A1 Naphthylethylurea and naphthylethylthiourea compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/03/1993 | EP0530058A1 1,2,4-Thiadiazino(3,4-b)benzothiazole derivatives, their preparation and medicaments containing them |
| 03/03/1993 | EP0529842A2 Production of fluoxetine and new intermediates |
| 03/03/1993 | EP0529636A1 Novel isatinoxime derivatives, their preparation and use |
| 03/03/1993 | EP0529499A1 Compositions for topical administration to the nose or the eyes containing bradykinin antagonists |
| 03/03/1993 | EP0529462A1 Benzodioxan derivatives |
| 03/03/1993 | EP0528978A1 Controlled release dopamine and its use to stimulate nerve fiber growth |
| 03/03/1993 | EP0528968A1 (3-alkylthio propyl)-3 benzothiazoline derivatives, preparation thereof and drugs containing said derivatives. |
| 03/03/1993 | EP0528954A1 Human neuronal cell line |
| 03/03/1993 | EP0528926A1 Soluble peptide analogues containing binding sites |
| 03/03/1993 | EP0528891A1 Method for increasing blood-brain barrier permeability |
| 03/03/1993 | EP0446225B1 Medicament for treatment of pathological vascular permeability and plasma loss to tissue |
| 03/03/1993 | EP0321516B1 3-indolepyruvic acid derivatives and pharmaceutical use thereof |
| 03/03/1993 | CN1019974C 1,4-disubstituted-piperidinyl compounds and preparing method thereof |
| 03/02/1993 | US5190976 Neuroprotective |
| 03/02/1993 | US5190965 Phenoxyphenyl derivatives, compositions and methods of use thereof |
| 03/02/1993 | US5190947 Analgesics |
| 03/02/1993 | US5190946 Piperazine compounds restore sensitivity to drug resistant cancer cells |
| 03/02/1993 | US5190939 Antihypoxic |
| 03/02/1993 | US5190923 Peptide compounds containing a cyclic amide structure |
| 03/02/1993 | US5190763 Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
| 03/02/1993 | CA1314050C Aminotetrahydro-5,6,7,8-naphto(2,3b) furane derivatives, processes for their preparation and pharmaceutical compositions holding same |
| 02/24/1993 | EP0528500A2 A method for reduction of central nervous system (CNS) edema resulting from head and spinal cord trauma |